Global Amyotrophic Lateral Sclerosis Treatment Market, By Type (Sporadic ALS, Familial ALS), Drug Type (Riluzole, Edaravone, Nuedexta), Treatment Type (Chemotherapy, Medication, Stem Cell Therapy, Physical Therapy, Respiratory Therapy, Speech Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail and Online Pharmacies), Diagnosis (Laboratory Tests, Imaging Tests), End User (Hospitals, Research and Academic Institutes, Diagnostic Centers, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028